INM: ADAR1 Capital Management, LLC; Schneeberger Daniel discloses a purchase

By AlphaYouPublished Sep 16, 2026Form 4

Stocks in this disclosure

Reported activity

ADAR1 Capital Management, LLC; Schneeberger Daniel

Reporting filer

ADAR1 Capital Management, LLC; Schneeberger Daniel reported Purchase in InMed Pharmaceuticals Inc.: 28505 units of Common Shares, dated 2026-09-14. The full Form 4 contains 3 transaction entries.

Disclosed: Sep 16, 2026

Reported details

3 entries

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Common Shares	ADAR1 Capital Management, LLC; Schneeberger Daniel	2026-09-14	P	Purchase	28505	1.2938	829,505	2 days	Filed terms security Title: Common Shares transaction Date: 2026-09-14 transaction Form Type: 4 transaction Code: P equity Swap Involved: 0 transaction Timeliness: transaction Shares: 28505 transaction Price Per Share: 1.2938 id: F1 transaction Acquired Disposed Code: A shares Owned Following Transaction: 829505 direct Or Indirect Ownership: I nature Of Ownership: See Footnote id: F4 id: F5
Common Shares	ADAR1 Capital Management, LLC; Schneeberger Daniel	2026-09-15	P	Purchase	54256	1.2984	883,761	1 day	Filed terms security Title: Common Shares transaction Date: 2026-09-15 transaction Form Type: 4 transaction Code: P equity Swap Involved: 0 transaction Timeliness: transaction Shares: 54256 transaction Price Per Share: 1.2984 id: F2 transaction Acquired Disposed Code: A shares Owned Following Transaction: 883761 direct Or Indirect Ownership: I nature Of Ownership: See Footnote id: F4 id: F5
Common Shares	ADAR1 Capital Management, LLC; Schneeberger Daniel	2026-09-16	P	Purchase	8340	1.289	892,101	0 days	Filed terms security Title: Common Shares transaction Date: 2026-09-16 transaction Form Type: 4 transaction Code: P equity Swap Involved: 0 transaction Timeliness: transaction Shares: 8340 transaction Price Per Share: 1.289 id: F3 transaction Acquired Disposed Code: A shares Owned Following Transaction: 892101 direct Or Indirect Ownership: I nature Of Ownership: See Footnote id: F4 id: F5

Common Shares

Owner: ADAR1 Capital Management, LLC; Schneeberger Daniel
Date: 2026-09-14
Code: P
Action: Purchase
Quantity: 28505
Price: 1.2938
Following holdings: 829,505
Reporting delay: 2 days
Filed terms and references: Filed terms
security Title: Common Shares
transaction Date: 2026-09-14
transaction Form Type: 4
transaction Code: P
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 28505
transaction Price Per Share: 1.2938
id: F1
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 829505
direct Or Indirect Ownership: I
nature Of Ownership: See Footnote
id: F4
id: F5

Common Shares

Owner: ADAR1 Capital Management, LLC; Schneeberger Daniel
Date: 2026-09-15
Code: P
Action: Purchase
Quantity: 54256
Price: 1.2984
Following holdings: 883,761
Reporting delay: 1 day
Filed terms and references: Filed terms
security Title: Common Shares
transaction Date: 2026-09-15
transaction Form Type: 4
transaction Code: P
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 54256
transaction Price Per Share: 1.2984
id: F2
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 883761
direct Or Indirect Ownership: I
nature Of Ownership: See Footnote
id: F4
id: F5

Common Shares

Owner: ADAR1 Capital Management, LLC; Schneeberger Daniel
Date: 2026-09-16
Code: P
Action: Purchase
Quantity: 8340
Price: 1.289
Following holdings: 892,101
Reporting delay: 0 days
Filed terms and references: Filed terms
security Title: Common Shares
transaction Date: 2026-09-16
transaction Form Type: 4
transaction Code: P
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 8340
transaction Price Per Share: 1.289
id: F3
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 892101
direct Or Indirect Ownership: I
nature Of Ownership: See Footnote
id: F4
id: F5

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
ADAR1 Capital Management, LLC: 10% owner.
Schneeberger Daniel: 10% owner.
F1: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.2900 to $1.3100, inclusive. Each Reporting Person undertakes to provide to InMed Pharmaceuticals Inc., any security holder of InMed Pharmaceuticals Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F2: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.2800 to $1.3000, inclusive. Each Reporting Person undertakes to provide to InMed Pharmaceuticals Inc., any security holder of InMed Pharmaceuticals Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F3: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.2600 to $1.3000, inclusive. Each Reporting Person undertakes to provide to InMed Pharmaceuticals Inc., any security holder of InMed Pharmaceuticals Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F4: The reported securities are owned directly by private investment funds managed by ADAR1 Capital Management, LLC, and may be deemed to be indirectly beneficially owned by (i) ADAR1 Capital Management, LLC and (ii) Daniel Schneeberger, the sole manager of ADAR1 Capital Management, LLC.
F5: For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.

Original sources

SEC ownership filing

Prepared automatically from public filing data. Report a correction.

Security

Owner

Date

Code

Action

Quantity

Price

Following holdings

Reporting delay

Filed terms and references

Common Shares

ADAR1 Capital Management, LLC; Schneeberger Daniel

2026-09-14

Purchase

28505

1.2938

829,505

2 days

Filed terms

security Title: Common Shares
transaction Date: 2026-09-14
transaction Form Type: 4
transaction Code: P
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 28505
transaction Price Per Share: 1.2938
id: F1
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 829505
direct Or Indirect Ownership: I
nature Of Ownership: See Footnote
id: F4
id: F5

Common Shares

ADAR1 Capital Management, LLC; Schneeberger Daniel

2026-09-15

Purchase

54256

1.2984

883,761

1 day

Filed terms

security Title: Common Shares
transaction Date: 2026-09-15
transaction Form Type: 4
transaction Code: P
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 54256
transaction Price Per Share: 1.2984
id: F2
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 883761
direct Or Indirect Ownership: I
nature Of Ownership: See Footnote
id: F4
id: F5

Common Shares

ADAR1 Capital Management, LLC; Schneeberger Daniel

2026-09-16

Purchase

8340

1.289

892,101

0 days

Filed terms

security Title: Common Shares
transaction Date: 2026-09-16
transaction Form Type: 4
transaction Code: P
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 8340
transaction Price Per Share: 1.289
id: F3
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 892101
direct Or Indirect Ownership: I
nature Of Ownership: See Footnote
id: F4
id: F5

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.

ADAR1 Capital Management, LLC: 10% owner.

Schneeberger Daniel: 10% owner.

F1: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.2900 to $1.3100, inclusive. Each Reporting Person undertakes to provide to InMed Pharmaceuticals Inc., any security holder of InMed Pharmaceuticals Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

F2: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.2800 to $1.3000, inclusive. Each Reporting Person undertakes to provide to InMed Pharmaceuticals Inc., any security holder of InMed Pharmaceuticals Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

F3: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.2600 to $1.3000, inclusive. Each Reporting Person undertakes to provide to InMed Pharmaceuticals Inc., any security holder of InMed Pharmaceuticals Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

F4: The reported securities are owned directly by private investment funds managed by ADAR1 Capital Management, LLC, and may be deemed to be indirectly beneficially owned by (i) ADAR1 Capital Management, LLC and (ii) Daniel Schneeberger, the sole manager of ADAR1 Capital Management, LLC.

F5: For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.